Premium
High frequency expressions of CD44 standard and variant forms in non‐small cell lung cancers, but not in small cell lung cancers
Author(s) -
Kondo Kazuya,
Miyoshi Takanori,
Hino Naoki,
Shimizu Eiji,
Masuda Noriyuki,
Takada Minoru,
Uyama Tadashi,
Monden Yasumasa
Publication year - 1998
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/(sici)1096-9098(199811)69:3<128::aid-jso3>3.0.co;2-m
Subject(s) - medicine , lung , cell , cd44 , pathology , oncology , small cell carcinoma , biology , genetics
Background and Objectives Organ specificity has been demonstrated in the mode of CD44 expression among several cancers. Methods We examined the expressions of CD44 standard (CD44s) and CD44 variants (CD44v) in 14 cell lines (small cell lung cancer (SCLC): 5, non‐small cell lung cancer (NSCLC): 9 and 20 surgically resected samples (SCLC: 7, NSCLC: 13) of lung cancer using reverse transcription‐polymerase chain reaction and immunohistochemistry. Results Although both NSCLC and SCLC expressed CD44s, the frequency and intensity of CD44s expression in NSCLC were different from those in SCLC: cell lines, 89% vs. 40%; tumor samples, 100% (diffusely stained) vs. 57% (focally stained). CD44s expression was partially or completely repressed in SCLC. However, NSCLC frequently expressed CD44v, but SCLC expressed infrequently: cell lines, 67% vs. 20%; tumor samples, 69% vs. 0%. The N‐417 line, which only expressed some CD44v in SCLC, falls SCLC and NSCLC both in biomarkers and in growth patterns. Conclusions CD44 expression was repressed in SCLC but was enhanced in NSCLC. J. Surg. Oncol. 1998;69:128–136. © 1998 Wiley‐Liss, Inc.